Frequently, drug research has focused on small agents, but amino acid alliances are rapidly demonstrating traction. This new strategy involves combining peptides with alternative biological methods to confront intricate illness pathways. By employing the specific properties of peptidic compounds – such as high precision and bioavailability – sc